On the other hand, loss of TGF-β receptors may weaken TGF-β-induced apoptosis, enhance cytokine secretion, and in inflammatory bowel disease promote the papilloma transformation and tumor angiogenesis [10], [15], [18], [25]–[27]. Here, TGFB1 is linked to inflammatory bowel disease.